Ipamorelin Structure
GHK-CU was first discovered in human plasma and later identified in saliva and urine, which highlighted its role in normal physiological processes related to tissue maintenance and repair
Emerging agents like the retatrutide peptide (a triple agonist targeting GLP-1, GIP, and Glucagon) and orforglipron peptide (an oral non-peptide GLP-1 agonist) are pushing the boundaries of what is possible in pharmacological weight loss, giving providers more options to tailor treatments to individual patient profiles
Beyond its ability to stimulate regeneration of skin, hair follicles, stomach and intestinal linings, and boney tissue, GHK-Cu strongly impacts gene expression relevant to nervous system health and function and may lessen the rate of cognitive decline [12]
Neuroprotection and Nerve Regeneration BPC-157 modulates neurotransmitters like dopamine and serotonin while supporting nerve growth and repair in both the central and peripheral nervous systems
It provides hydration that supports the cellular activity stimulated by GHK-Cu